☆ 4.8 Article

Immune-related adverse events: A bibliometric analysis

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Harnessing big data to characterize immune-related adverse events

Ying Jing et al.

Summary: Immune-checkpoint inhibitors (ICIs) have been associated with immune-related adverse events (irAEs), a unique spectrum of organ-specific inflammatory toxicities. Recent studies have utilized aggregate clinical data, real-world data, and multi-omics data to investigate the mechanisms and clinical presentations of irAEs. This Perspective provides a summary of the knowledge on irAEs obtained through different sources of "big data".

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Immunology

Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study

Jianming Shen et al.

Summary: This study conducted a bibliometric analysis on immunotherapy for hepatocellular carcinoma (HCC) to gain a better understanding of the current situation and potential new research directions. The study found that China is the main research country in this field, with the number of articles increasing every year. The current research hotspots include the immunological landscape of liver cancer, screening of eligible populations for immunotherapy, and the clinical application of immune checkpoint inhibitors.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies

Ryan J. Sullivan et al.

Summary: The Review by Weber and Sullivan highlights the different types of immune-related adverse events associated with checkpoint inhibitors and discusses how their treatment and identification of possible predictive biomarkers may shed light on their mechanisms, as well as possible strategies and targets for prophylactic and therapeutic interventions to mitigate them.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Immunology

Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021

Long Ma et al.

Summary: Immunotherapy is crucial in the treatment of colorectal cancer (CRC) and research in this field has been growing. The study analyzed regions, institutions, journals, authors, and keywords to predict the latest trends in CRC immunotherapy research. The United States and China were the major contributors, with T cell and immune checkpoint inhibitors being the focus of research.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021

Zhanpeng Ou et al.

Summary: CAR-based immunotherapy is a promising treatment for cancer patients, and there is an emerging movement toward using advanced gene modification technologies to overcome therapeutic challenges, especially in solid tumors, and to generate safer and more effective universal CAR-engineered cell products.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis

Yanhao Liu et al.

Summary: This study used bibliometric analysis to identify influential clinical studies and research trends in anti-PD1/PDL1 immunotherapy. The most well-studied cancers were lung cancer and melanoma, and the most influential journal in this area was the New England Journal of Medicine. Further research is needed to identify effective predictive biomarkers, clarify the molecular mechanisms of combined therapy, and establish optimal treatment strategies.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Alexandra Pender et al.

Summary: The study investigated the use of WGTA to analyze fresh tumor biopsies from 98 patients with metastatic tumors, revealing that tumor mutation burden, CD8(+) T-cell, and M1-M2 macrophage ratios were significant predictors of treatment response. Combining multiple biomarkers based on WGTA allows for better identification of responders to immune checkpoint inhibitors in a heterogeneous population of advanced and previously treated cancers.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Review Oncology

Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review

Joosje C. Baltussen et al.

Summary: Immune checkpoint inhibitors have significantly improved the survival of melanoma patients, but durable responses are only seen in a minority, highlighting the need for predictive biomarkers. A systematic review of 177 publications investigating 128 unique biomarkers found T-cell inflamed gene expression profiling as a promising biomarker, while noting high heterogeneity and low sample sizes in current studies. Future research is needed to further explore the utility of candidate biomarkers in melanoma patients receiving ICIs.

CANCERS (2021)

添加到收藏夹

Article Oncology

Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis

Melissa L. Bastacky et al.

Summary: This study of 190 metastatic melanoma patients treated with single-agent anti-PD-1 ICI therapy found that 60% experienced at least one immune-related adverse event (irAEs), with irAE occurrence significantly associated with response to anti-PD-1 therapy. Patients with multiple irAEs exhibited distinct patterns, and obesity was distinctly associated with irAE development, while age and gender showed no significant association.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Immunology

Global Trends in Research of Macrophages Associated With Acute Lung Injury Over Past 10 Years: A Bibliometric Analysis

Sheng Wang et al.

Summary: Over the past 10 years, research on macrophages in acute lung injury (ALI) has shown a continuous increase, with China being a major producer of studies and the USA exerting significant influence in the field. Studies have mainly focused on basic research, with recent attention shifting towards pathways associated with the regulatory role of macrophages in inhibiting and attenuating ALI.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

A Bibliometric Analysis of Pyroptosis From 2001 to 2021

Dan Ma et al.

Summary: Pyroptosis is a newly discovered programmed cell death, with increasing research focus and trends revealed through bibliometric analysis. The importance of pyroptosis in various diseases was highlighted, underscoring the need for enhanced international collaboration in future research endeavors.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Information Science & Library Science

Web of Science (WoS) and Scopus: The Titans of Bibliographic Information in Today's Academic World

Raminta Pranckute

Summary: The importance of bibliographic databases has greatly increased, and choosing the most suitable one is crucial for users. Factors such as coverage, interface convenience, performance, impact indicators, and additional tools should be considered. By gathering recent research and information from DB owners, users can make informed decisions when selecting a database.

PUBLICATIONS (2021)

添加到收藏夹

Article Oncology

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution

R. Kleef et al.

Summary: This study found a safer and effective treatment approach through combination therapy for patients with 23 different types of cancers, offering good efficacy without compromising safety.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Immune-related adverse events of checkpoint inhibitors

Manuel Ramos-Casals et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

添加到收藏夹

Review Oncology

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC

D. Ross Camidge et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Meeting Abstract Immunology

Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer

Ane Marie Anderson et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)

添加到收藏夹

Review Social Sciences, Interdisciplinary

Citations, Citation Indicators, and Research Quality: An Overview of Basic Concepts and Theories

Dag W. Aksnes et al.

SAGE OPEN (2019)

添加到收藏夹

Article Oncology

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Oncology

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis

Daniel Y. Wang et al.

JAMA ONCOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

Cheng Xu et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Citation-based clustering of publications using CitNetExplorer and VOSviewer

Nees Jan van Eck et al.

SCIENTOMETRICS (2017)

添加到收藏夹

Article Oncology

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

I. Puzanov et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

添加到收藏夹

Review Oncology

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

J. M. Michot et al.

EUROPEAN JOURNAL OF CANCER (2016)

添加到收藏夹

Review Oncology

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

Geoffrey T. Gibney et al.

LANCET ONCOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. dbj Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Review Oncology

Immune Checkpoint Blockade in Cancer Therapy

Michael A. Postow et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Review Oncology

CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

Luis H. Camacho

CANCER MEDICINE (2015)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

The relationship between the research performance of scientists and their position in co-authorship networks in three fields

Maria Bordons et al.

JOURNAL OF INFORMETRICS (2015)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

The expansion of Google Scholar versus Web of Science: a longitudinal study

Joost C. F. de Winter et al.

SCIENTOMETRICS (2014)

添加到收藏夹

Article Oncology

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

Jeffrey S. Weber et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Software survey: VOSviewer, a computer program for bibliometric mapping

Nees Jan van Eck et al.

SCIENTOMETRICS (2010)

添加到收藏夹

Article Communication

A bibliometric analysis of communication journals from 2002 to 2005

Thomas Hugh Feeley

HUMAN COMMUNICATION RESEARCH (2008)

添加到收藏夹

Article Computer Science, Information Systems

CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature

CM Chen

JOURNAL OF THE AMERICAN SOCIETY FOR INFORMATION SCIENCE AND TECHNOLOGY (2006)

添加到收藏夹

Article Oncology

Mesenchymal stem cells induce apoptosis of activated T cells

J Plumas et al.

LEUKEMIA (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.